District of Columbia · 2025-2026 Regular Session
As introduced, Bill 26-159 would prohibit health benefit plans and health insurers from using prescription information as a condition of eligibility or to set premium rates. It would prohibit insurers from restricting or imposing delays in the distribution of antiretroviral prescription drugs prescribed to a person for the treatment or prevention of the human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS). It would also prohibit health insurers from imposing a deductible, coinsurance, copayment, or other cost-sharing requirement for PrEP or PEP to prevent HIV and AIDS infection. NOTE - Incorporates provisions of Bill 26-101, Removing Barriers and Reducing Stigma to Encourage HIV Prevention Amendment Act of 2025.
Law Number L26-0115 Effective from May 21, 2026 (2026-05-21)